Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/102023
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPuri, R.-
dc.contributor.authorNissen, S.-
dc.contributor.authorShao, M.-
dc.contributor.authorUno, K.-
dc.contributor.authorKataoka, Y.-
dc.contributor.authorKapadia, S.-
dc.contributor.authorTuzcu, E.-
dc.contributor.authorNicholls, S.-
dc.date.issued2014-
dc.identifier.citationAmerican Journal of Cardiology, 2014; 114(10):1465-1472-
dc.identifier.issn0002-9149-
dc.identifier.issn1879-1913-
dc.identifier.urihttp://hdl.handle.net/2440/102023-
dc.description.abstractAbstract not available-
dc.description.statementofresponsibilityR. Puri, S.E. Nissen, M. Shao, K. Uno, Y. Kataoka, S.R. Kapadia, E.M. Tuzcu and S.J. Nicholls-
dc.language.isoen-
dc.publisherElsevier-
dc.rights© 2014 Elsevier Inc. All rights reserved.-
dc.source.urihttp://dx.doi.org/10.1016/j.amjcard.2014.08.009-
dc.subjectHumans-
dc.subjectDisease Progression-
dc.subjectLipoproteins-
dc.subjectC-Reactive Protein-
dc.subjectBiological Markers-
dc.subjectHydroxymethylglutaryl-CoA Reductase Inhibitors-
dc.subjectCoronary Angiography-
dc.subjectUltrasonography, Interventional-
dc.subjectTreatment Outcome-
dc.subjectFollow-Up Studies-
dc.subjectProspective Studies-
dc.subjectDose-Response Relationship, Drug-
dc.subjectMiddle Aged-
dc.subjectFemale-
dc.subjectMale-
dc.subjectCoronary Artery Disease-
dc.subjectPlaque, Atherosclerotic-
dc.titleImpact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy-
dc.typeJournal article-
dc.identifier.doi10.1016/j.amjcard.2014.08.009-
pubs.publication-statusPublished-
dc.identifier.orcidPuri, R. [0000-0001-8849-7426]-
dc.identifier.orcidNicholls, S. [0000-0002-9668-4368]-
Appears in Collections:Aurora harvest 7
Medical Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.